Suchergebnisse - "Xiao, Lu-Shan"

PubPharm (23)

1

Efficacy and safety of different PD-1 inhibitors in combination with lenvatinib in the treatment of unresectable primary liver cancer : a multicentre retrospective study

enthalten in: Discover. Oncology | 2023

von Li, Q. | Sun, Q. | Jian, Y. | +13

2

Efficacy and safety of different PD-1 inhibitors in combination with lenvatinib in the treatment of unresectable primary liver cancer: a multicentre retrospective study

enthalten in: Discover oncology | 2023

von Li, Q. | Sun, Q. | Jian, Y. | +13

3

Efficacy and safety of different PD-1 inhibitors in combination with lenvatinib in the treatment of unresectable primary liver cancer: a multicentre retrospective study

enthalten in: Hormones and cancer | 2023

von Li, Q. | Sun, Q. | Jian, Y. | +13

4

Characteristics of patients with SARS-COV-2 PCR re-positivity after recovering from COVID-19

enthalten in: Epidemiology and infection | 2023

von Hu, C. | Lei, Y. | Tang, Y. | +8

5

Predictive Value of the Hepatic Immune Predictive Index for Patients with Primary Liver Cancer Treated with Immune Checkpoint Inhibitors

enthalten in: Digestive diseases (Basel, Switzerland) | 2023

von Hong, C. | Dong, H. | Li, R. | +9

6

Splenomegaly in predicting the survival of patients with advanced primary liver cancer treated with immune checkpoint inhibitors

enthalten in: Cancer medicine | 2022

von Xiao, L. | Hu, C. | Cui, H. | +7

7

CT images-based 3D convolutional neural network to predict early recurrence of solitary hepatocellular carcinoma after radical hepatectomy

enthalten in: Diagnostic and interventional radiology (Ankara, Turkey) | 2022

von Cui, H. | Wang, K. | Li, W. | +3

8

Use of computed tomography-derived body composition to determine the prognosis of patients with primary liver cancer treated with immune checkpoint inhibitors : a retrospective cohort study

enthalten in: BMC cancer | 2022

von Xiao, L. | Li, R. | Cui, H. | +7

9

Use of computed tomography-derived body composition to determine the prognosis of patients with primary liver cancer treated with immune checkpoint inhibitors: a retrospective cohort study

enthalten in: BMC cancer | 2022

von Xiao, L. | Li, R. | Cui, H. | +7

10

Organ-specific metastatic landscape dissects PD-(L)1 blockade efficacy in advanced non-small cell lung cancer : applicability from clinical trials to real-world practice

enthalten in: BMC medicine | 2022

von Ma, S. | Bai, X. | Guo, X. | +15